Streetbeat News

FEMY

Femasys Inc.

https://www.femasys.com

Industry

Medical - Instruments & Supplies

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Open

0.99

Mkt cap

22M

Volume

141K

High

1.00

P/E Ratio

-1.13

52-wk high

2.40

Low

0.95

Div yield

N/A

52-wk low

0.73

Healthcare stocks showed significant movement in Wednesday's after-market session. Gritstone Bio, Avinger, BioSig Technologies, Aytu BioPharma, Omeros, and CASI Pharmaceuticals saw increases, with Gritstone Bio leading with a 37% rise. SeaStar Medical Holding, Monogram Orthopaedics, INVO Bioscience, Avalo Therapeutics, Femasys, and Impel Pharmaceuticals experienced decreases, with SeaStar Medical Holding falling by 10%.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 9:31 pm

Femasys Inc. (NASDAQ:FEMY) shares fell by 24% on Wednesday, following a surge in price on Tuesday due to the announcement of FDA 510(k) clearance for FemaSeed, an infertility treatment. The stock experienced an above-average trading volume of 15.73 million shares compared to its average volume of 6.76 million.

Portfolio Pulse from Ryan Gustafson

September 27, 2023 | 8:00 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Gainers included MSP Recovery (LIFW), Biohaven (BHVN), SeaStar Medical Holding (ICU), Context Therapeutics (CNTX), Streamline Health Solns (STRM), and Galecto (GLTO). Losers included Sharps Technology (STSS), Minerva Surgical (UTRS), Know Labs (KNW), Tharimmune (THAR), Femasys (FEMY), and Synlogic (SYBX).

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 5:31 pm

Several stocks experienced significant movement in Wednesday's mid-day session. ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 152.8% after announcing the effective date for its reverse stock split. SciSparc Ltd. (NASDAQ:SPRC) gained 120.9% as it reported its 1-for-26 reverse share split is expected to be implemented after market close. Rite Aid Corporation (NYSE:RAD) climbed 44% following a substantial settlement agreement of $230 million by consulting firm McKinsey & Company related to opioid addiction lawsuits. On the other hand, Sharps Technology, Inc. (NASDAQ:STSS) fell 31.6% after reporting a $5.6 million registered direct and private placement priced at the market under Nasdaq rules.

Portfolio Pulse from Lisa Levin

September 27, 2023 | 4:48 pm

During Wednesday's pre-market session, several healthcare stocks saw significant movement. Galecto (GLTO), MSP Recovery (LIFW), Cardiff Oncology (CRDF), Intelligent Bio Solutions (INBS), Biohaven (BHVN), and Eledon Pharma (ELDN) all saw increases, with Galecto leading the gainers with a 31.3% increase. On the other hand, Know Labs (KNW), Minerva Surgical (UTRS), Femasys (FEMY), Tharimmune (THAR), DMK Pharmaceuticals (DMK), and Adial Pharmaceuticals (ADIL) all experienced decreases, with Know Labs leading the losers with a 36.5% decrease.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 1:06 pm

Femasys has activated enrollment for its pivotal FemBloc trial at its first academic site in Brooklyn, New York. The trial will investigate the safety and efficacy of its investigational permanent birth control candidate.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:03 pm

Several healthcare stocks experienced significant movement in Tuesday's after-market session. Galecto, Exagen, MSP Recovery, Brainstorm Cell, VYNE Therapeutics, and Freeline Therapeutics saw increases, while Minerva Surgical, Femasys, DMK Pharmaceuticals, Adial Pharmaceuticals, Tharimmune, and SeqLL experienced decreases.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 9:31 pm

US stocks traded lower with the Dow Jones falling more than 400 points and NASDAQ falling 1.48%. United Natural Foods Inc reported mixed results for its fourth quarter, missing sales growth consensus but beating EPS consensus. The company's shares fell by 25%. Soleno Therapeutics, Femasys Inc, and Immunovant saw significant increases in their share prices due to positive news. TransCode Therapeutics and New Pacific Metals Corp saw their shares drop.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 6:26 pm

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Soleno Therapeutics (SLNO), Femasys (FEMY), DMK Pharmaceuticals (DMK), Immunovant (IMVT), Intercept Pharma (ICPT), and Applied Therapeutics (APLT) saw their shares rise, with Soleno Therapeutics leading the gainers with a 426.2% increase. On the other hand, TransCode Therapeutics (RNAZ), Fresh2 Group (FRES), Novo Integrated Sciences (NVOS), Candel Therapeutics (CADL), Know Labs (KNW), and Vaccitech (VACC) saw their shares decline, with TransCode Therapeutics leading the losers with a 71.7% decrease.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 5:31 pm

Several stocks experienced significant movement in Tuesday's mid-day session. Soleno Therapeutics, Femasys, Intercept Pharmaceuticals, Immunovant, Tharimmune, Acasti Pharma, Cano Health, Bullfrog AI Holdings, Avalo Therapeutics, Adaptive Biotechnologies, Infobird, ARS Pharmaceuticals, Roivant Sciences, Verve Therapeutics, Pliant Therapeutics, Fisker, Planet Green Holdings, BYND Cannasoft Enterprises, Acutus Medical, Aclarion, Vera Therapeutics, Blue Star Foods, NightHawk Biosciences, and Precigen saw gains. Meanwhile, TransCode Therapeutics, Murphy Canyon Acquisition, Davis Commodities, Molekule Group, Polished.com, United Natural Foods, MicroAlgo, Genetron Holdings, Greenfire Resources, Novo Integrated Sciences, Ebix, New Pacific Metals, Biophytis, Roadzen, Akili, FaZe Holdings, MSP Recovery, TROOPS, Sacks Parente Golf, and TD SYNNEX experienced losses.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 4:56 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.